sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓÕ·¢ÐÔÁܰÍÁö¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢ÐÔÁܰÍÁö¶¯ÎïÄ£×Ó

ǰÑÔ

ÁܰÍÁö(lymphoma)ÊDZ¬·¢ÓÚÁÜͶºÏ¼°£¨»ò£©ÁÜͶºÏÍâÁܰÍ×éÖ¯µÄ¶ñÐÔÖ×Áö £¬ÊÇÒ»Àà°üÀ¨¶àÖÖ²î±ðÁÙ´²ÌåÏֺͷÖ×ÓÉúÎïÑ§ÌØÕ÷µÄÖ×Áö¡£½üÄêÀ´ £¬Ëæ×۬×̲¡¼°¼Ì·¢ÐÔÃâÒßÒÖÖÆ¼²²¡µÄÔö¶à £¬Æä·¢²¡ÂÊÔÚÌìϸ÷¹úÏÔ×ÅÉÏÉý £¬µ«Æä»ù´¡ºÍÁÙ´²Ñо¿Éî¶ÈºÍ¹ã¶ÈÈÔºÜÓÐÏÞ¡£½üÄêÀ´ £¬ÈËÃÇÏà¼Ì½¨ÉèÖÖÖÖÁܰÍÁö¶¯ÎïÄ£×Ó £¬´Ó×Ô¾õÐÔ¡¢ÓÕ·¢ÐÔÖ×ÁöÄ£×Óµ½ÆÕ±éÔËÓõÄÒÆÖ²ÐÔÖ×ÁöÄ£×ÓÒÔ¼°ÔËÓ÷Ö×ÓÉúÎïѧÊÖÒÕ½¨ÉèµÄת»ùÒò¶¯ÎïÄ£×ÓµÈ £¬ÕâЩģ×ÓΪÉîÈëÑо¿ÁܰÍÁö²¡Òò¡¢·¢²¡»úÖÆ¡¢Õï¶ÏºÍÖÎÁƵÈÌṩÁËÓÐÓõÄÑо¿ÊֶΡ£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×î³£ÓõÄÓÕµ¼¼ÁÊÇN£­¼×»ùÑÇÏõ»ùëå(MNU)¡£ÆäÖ°©»úÖÆÓëO6£­¼×»ùÄñàÑßÊÐγÉÓйØ £¬ÖÂʹDNA¸´ÖÆÀú³ÌÖб¬·¢GyAµãÍ»±ä¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ͨ¹ý¸¹Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈ¸øÒ©ÒªÁì £¬µ¥´Î»ò·Ö´Î¸øÒ© £¬¾ù¿ÉÓÕµ¼¶àƷϵСÊ󱬷¢ÐØÏÙÁܰÍÁö¡£ÏÖÔÚ×î³£ÓõÄÊǸ¹Ç»×¢Éä·¨£ºÒÔ8mlµÄDMSO 92mlµÄ0.01mol/L PBS(pH=7.2)ΪÈܼÁ £¬½«MNUÅä³ÉŨ¶ÈΪ10mg/mlµÄÓÕµ¼Òº £¬¼´Óü´Å䡣ѡÓÃ6~8ÖÜSPF C57BL/6СÊó £¬êòĵ¾ù¿É¡£¸¹Ç»×¢ÉäMNUÓÕµ¼Òº(50mg/kgÌåÖØ£© £¬¹²×¢Éä2´Î£¨»®·ÖÓÚµÚ0¡¢8ÖÜ£©¡£×¢Éä×îÏȺó¼ÌÐø»ù´¡Òûʳ £¬²¢ÊӲ춯ÎïÌåÖØ¡¢Òûʳ¡¢Ã«É«¡¢Ô˶¯¶ÈµÈÒ»Ñùƽ³£ÇéÐÎת±ä¡£

¡¾Ä£×ÓÌØµã¡¿£º

¢ÙMNUÓÕµ¼µÄСÊóÐØÏÙÁܰÍÁöµÄÐγÉÀú³ÌÏÖʵÉÏÊǵ¥¸öTÁܰÍϸ°ûTCR»ùÒòÖØÅźó £¬ÔÚMNUµÄ×÷ÓÃϱ¬·¢¶ñÐÔת»¯ £¬²¢µ¥¿Ë¡ÐÔÔöÉú £¬×îÖÕÈ¡´úÐØÏÙÄÚÕý³£Ï¸°û £¬ÊÇÊôÓÚTϸ°ûȪԴµÄÖ×Áö¡£¢Ú¹âѧÏÔ΢¾µÏÂÐØÏÙ½á¹¹ÆÆË𠣬ÒÔÃÖÂþÂþÑܵÄÖеȾÞϸµÄÁܰÍÑùÖ×Áöϸ°û´úÖ®¡£¢Û¿É¸¹ Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈÒªÁìµ¥´Î»ò·Ö´Î¸øÒ© £¬¾ù¿ÉÓÕ·¢²î±ðƷϵµÄ¶¯Îﱬ·¢ÁܰÍÁö £¬µ«·¢²¡ÂÊÓÐËù²î±ð¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÒªÁìÇáÓ¯Ò×ÐÐ £¬³ÉÁöµÄÏà¶ÔÖÜÆÚ¶Ì¼°ÖÂÁöÂʸߣ»»¯Ñ§Ö°©Îï³£ÓÕ·¢¶à²¿Î»Ö×Áö £¬¹Ê²»³£ÓÃÓÚÒ©ÎïɸÑ¡£»´Ó²¡Òòѧ½Ç¶È¿´ £¬ËüÓëÈËÌåÖ×Áö½ÏΪ½üËÆ £¬¹Ê´ËÄ£×Ó³£ÓÃÓÚÌØ¶¨µÄÉîÈëÑо¿¡£

 

²Î¿¼ÎÄÏ×£º

1.ÓÚÀ× £¬ÁõÓÀÕÜ £¬ËïÊÀÁú £¬µÈ£®c-myc»ùÒòÓë·øÉäÓÕ·¢Ð¡ÊóÐØÏÙÁܰÍÁöµÄ¹ØÁªÐÔÆÊÎö£®¼ªÁÖ´óѧѧ±¨£¨Ò½Ñ§°æ£© £¬2009, 35 (6):971-974

2.ÒüÖ¾»ª £¬ÌÚ·É £¬ÌÆÔËÁ« £¬µÈ£®»·æßËØA¶ÔÎȹÌEBVÓÕ·¢ÁܰÍÁöÄ£×ÓµÄ×÷ÓúÍÒâÒ壮ÖйúÃâÒßѧÔÓÖ¾ £¬2002, 18(11):760-763

3.ÇñÑǾê £¬ÕÅÃ÷ÖÇ £¬ÀîÁᣮEB²¡¶¾ÓëÁܰÍÁö£®¹ú¼ÊÖ×ÁöѧÔÓÖ¾ £¬2011, 38 (5):387-389

4.»Æ¸ñ·¼ £¬ÓàÓ¢ºÀ £¬À£®N£­¼×»ùÑÇÏõ»ùëåÓÕµ¼Ð¡ÊóÐØÏÙÁܰÍÁöTCR»ùÒòÖØÅÅÆÊÎö£®Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾ £¬2010,20(9):7-11

5.Xu D,Wang S,Yu WM,et al. A germline gain-of­ function mutation in Ptpnl 1 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood,2010, 116(18):3611- 3621

6.Chen HJ.Yang BL,Chen YG,et al. A GFP-labeled human colon cancer metastasis model featuring surgical orthotopic implantation. Asian Pac J Cancer Prev, 2012, 13 (9):4263-4266

7.Chiarle R,Gong JZ,Guasparri¢ñ,et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood, 2003, 101 (5):1919-1927

8.Wang S, Yu WM, Zhang W, et al. Noonan syndrome/ leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN 11) enhance cell migration and angiogenesis. J Biol Chem,2009,284(2):913-920

9.Benavides F, Gomez  G, Venables-Griffith A, et al.Differential susceptibility to chemically induced thymic lymphomas in SENGARB and SSIN inbred mice. Mol Carcinog,2006,45 (7):543-548

10.da Silva Franchi CA,Bacchi MM,et al. Thymic lymphomas in Wistar rats exposed to N-methyl-N­ nitrosourea (MNU). Cancer Sci,2003,94(3):240-243

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢ÐÔÁܰÍÁö¶¯ÎïÄ£×Ó
ÓÕ·¢ÐÔÁܰÍÁö¶¯ÎïÄ£×Ó

ǰÑÔ

ÁܰÍÁö(lymphoma)ÊDZ¬·¢ÓÚÁÜͶºÏ¼°£¨»ò£©ÁÜͶºÏÍâÁܰÍ×éÖ¯µÄ¶ñÐÔÖ×Áö £¬ÊÇÒ»Àà°üÀ¨¶àÖÖ²î±ðÁÙ´²ÌåÏֺͷÖ×ÓÉúÎïÑ§ÌØÕ÷µÄÖ×Áö¡£½üÄêÀ´ £¬Ëæ×۬×̲¡¼°¼Ì·¢ÐÔÃâÒßÒÖÖÆ¼²²¡µÄÔö¶à £¬Æä·¢²¡ÂÊÔÚÌìϸ÷¹úÏÔ×ÅÉÏÉý £¬µ«Æä»ù´¡ºÍÁÙ´²Ñо¿Éî¶ÈºÍ¹ã¶ÈÈÔºÜÓÐÏÞ¡£½üÄêÀ´ £¬ÈËÃÇÏà¼Ì½¨ÉèÖÖÖÖÁܰÍÁö¶¯ÎïÄ£×Ó £¬´Ó×Ô¾õÐÔ¡¢ÓÕ·¢ÐÔÖ×ÁöÄ£×Óµ½ÆÕ±éÔËÓõÄÒÆÖ²ÐÔÖ×ÁöÄ£×ÓÒÔ¼°ÔËÓ÷Ö×ÓÉúÎïѧÊÖÒÕ½¨ÉèµÄת»ùÒò¶¯ÎïÄ£×ÓµÈ £¬ÕâЩģ×ÓΪÉîÈëÑо¿ÁܰÍÁö²¡Òò¡¢·¢²¡»úÖÆ¡¢Õï¶ÏºÍÖÎÁƵÈÌṩÁËÓÐÓõÄÑо¿ÊֶΡ£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×î³£ÓõÄÓÕµ¼¼ÁÊÇN£­¼×»ùÑÇÏõ»ùëå(MNU)¡£ÆäÖ°©»úÖÆÓëO6£­¼×»ùÄñàÑßÊÐγÉÓйØ £¬ÖÂʹDNA¸´ÖÆÀú³ÌÖб¬·¢GyAµãÍ»±ä¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ͨ¹ý¸¹Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈ¸øÒ©ÒªÁì £¬µ¥´Î»ò·Ö´Î¸øÒ© £¬¾ù¿ÉÓÕµ¼¶àƷϵСÊ󱬷¢ÐØÏÙÁܰÍÁö¡£ÏÖÔÚ×î³£ÓõÄÊǸ¹Ç»×¢Éä·¨£ºÒÔ8mlµÄDMSO 92mlµÄ0.01mol/L PBS(pH=7.2)ΪÈܼÁ £¬½«MNUÅä³ÉŨ¶ÈΪ10mg/mlµÄÓÕµ¼Òº £¬¼´Óü´Å䡣ѡÓÃ6~8ÖÜSPF C57BL/6СÊó £¬êòĵ¾ù¿É¡£¸¹Ç»×¢ÉäMNUÓÕµ¼Òº(50mg/kgÌåÖØ£© £¬¹²×¢Éä2´Î£¨»®·ÖÓÚµÚ0¡¢8ÖÜ£©¡£×¢Éä×îÏȺó¼ÌÐø»ù´¡Òûʳ £¬²¢ÊӲ춯ÎïÌåÖØ¡¢Òûʳ¡¢Ã«É«¡¢Ô˶¯¶ÈµÈÒ»Ñùƽ³£ÇéÐÎת±ä¡£

¡¾Ä£×ÓÌØµã¡¿£º

¢ÙMNUÓÕµ¼µÄСÊóÐØÏÙÁܰÍÁöµÄÐγÉÀú³ÌÏÖʵÉÏÊǵ¥¸öTÁܰÍϸ°ûTCR»ùÒòÖØÅźó £¬ÔÚMNUµÄ×÷ÓÃϱ¬·¢¶ñÐÔת»¯ £¬²¢µ¥¿Ë¡ÐÔÔöÉú £¬×îÖÕÈ¡´úÐØÏÙÄÚÕý³£Ï¸°û £¬ÊÇÊôÓÚTϸ°ûȪԴµÄÖ×Áö¡£¢Ú¹âѧÏÔ΢¾µÏÂÐØÏÙ½á¹¹ÆÆË𠣬ÒÔÃÖÂþÂþÑܵÄÖеȾÞϸµÄÁܰÍÑùÖ×Áöϸ°û´úÖ®¡£¢Û¿É¸¹ Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈÒªÁìµ¥´Î»ò·Ö´Î¸øÒ© £¬¾ù¿ÉÓÕ·¢²î±ðƷϵµÄ¶¯Îﱬ·¢ÁܰÍÁö £¬µ«·¢²¡ÂÊÓÐËù²î±ð¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÒªÁìÇáÓ¯Ò×ÐÐ £¬³ÉÁöµÄÏà¶ÔÖÜÆÚ¶Ì¼°ÖÂÁöÂʸߣ»»¯Ñ§Ö°©Îï³£ÓÕ·¢¶à²¿Î»Ö×Áö £¬¹Ê²»³£ÓÃÓÚÒ©ÎïɸÑ¡£»´Ó²¡Òòѧ½Ç¶È¿´ £¬ËüÓëÈËÌåÖ×Áö½ÏΪ½üËÆ £¬¹Ê´ËÄ£×Ó³£ÓÃÓÚÌØ¶¨µÄÉîÈëÑо¿¡£

 

²Î¿¼ÎÄÏ×£º

1.ÓÚÀ× £¬ÁõÓÀÕÜ £¬ËïÊÀÁú £¬µÈ£®c-myc»ùÒòÓë·øÉäÓÕ·¢Ð¡ÊóÐØÏÙÁܰÍÁöµÄ¹ØÁªÐÔÆÊÎö£®¼ªÁÖ´óѧѧ±¨£¨Ò½Ñ§°æ£© £¬2009, 35 (6):971-974

2.ÒüÖ¾»ª £¬ÌÚ·É £¬ÌÆÔËÁ« £¬µÈ£®»·æßËØA¶ÔÎȹÌEBVÓÕ·¢ÁܰÍÁöÄ£×ÓµÄ×÷ÓúÍÒâÒ壮ÖйúÃâÒßѧÔÓÖ¾ £¬2002, 18(11):760-763

3.ÇñÑǾê £¬ÕÅÃ÷ÖÇ £¬ÀîÁᣮEB²¡¶¾ÓëÁܰÍÁö£®¹ú¼ÊÖ×ÁöѧÔÓÖ¾ £¬2011, 38 (5):387-389

4.»Æ¸ñ·¼ £¬ÓàÓ¢ºÀ £¬À£®N£­¼×»ùÑÇÏõ»ùëåÓÕµ¼Ð¡ÊóÐØÏÙÁܰÍÁöTCR»ùÒòÖØÅÅÆÊÎö£®Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾ £¬2010,20(9):7-11

5.Xu D,Wang S,Yu WM,et al. A germline gain-of­ function mutation in Ptpnl 1 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood,2010, 116(18):3611- 3621

6.Chen HJ.Yang BL,Chen YG,et al. A GFP-labeled human colon cancer metastasis model featuring surgical orthotopic implantation. Asian Pac J Cancer Prev, 2012, 13 (9):4263-4266

7.Chiarle R,Gong JZ,Guasparri¢ñ,et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood, 2003, 101 (5):1919-1927

8.Wang S, Yu WM, Zhang W, et al. Noonan syndrome/ leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN 11) enhance cell migration and angiogenesis. J Biol Chem,2009,284(2):913-920

9.Benavides F, Gomez  G, Venables-Griffith A, et al.Differential susceptibility to chemically induced thymic lymphomas in SENGARB and SSIN inbred mice. Mol Carcinog,2006,45 (7):543-548

10.da Silva Franchi CA,Bacchi MM,et al. Thymic lymphomas in Wistar rats exposed to N-methyl-N­ nitrosourea (MNU). Cancer Sci,2003,94(3):240-243

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿